Ben R. Taylor - Dec 16, 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Financial Officer
Signature
Jonathan D. Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Dec 16, 2024
Transactions value $
-$143,681
Form type
4
Date filed
12/18/2024, 06:49 PM
Previous filing
Dec 2, 2024
Next filing
Dec 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Tax liability -$94.6K -15.7K -3.16% $6.04 481K Dec 16, 2024 Direct F1
transaction RXRX Class A Common Stock Tax liability -$49K -7.06K -1.47% $6.95 474K Dec 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.